Skip to main content
ARDELYX, INC. logo

ARDELYX, INC. — Investor Relations & Filings

Ticker · ARDX ISIN · US0396971071 LEI · 549300F542QR4SXHCY32 US Manufacturing
Filings indexed 1,078 across all filing types
Latest filing 2019-03-06 Earnings Release
Country US United States of America
Listing US ARDX

About ARDELYX, INC.

https://www.ardelyx.com/

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 6, 2019, by Ardelyx, Inc. It announces the company's financial results for the fourth quarter and year ended December 31, 2018. The text explicitly states that the full text of the press release is furnished as an exhibit to this Form 8-K. The document itself is short (3239 characters) and primarily serves as an announcement of the earnings release rather than containing detailed financial data or analysis. According to the rules, such a document is best classified as an Earnings Release (ER) since it is the initial announcement of quarterly/periodical financial results with key highlights only, and it is not a full quarterly or annual report. The Form 8-K is a common vehicle for earnings releases. Therefore, the classification is ER with high confidence.
2019-03-06 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-19 English
SCHEDULE 13G HOLDINGS REPORT AMENDMENT
Major Shareholding Notification
2019-02-14 English
ARDELYX, INC.
Major Shareholding Notification
2019-02-13 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-08 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.